Is STARD3 A New Biomarker for Breast Cancer?

Breast STARD3 cancer lipid

Journal

European journal of breast health
ISSN: 2587-0831
Titre abrégé: Eur J Breast Health
Pays: Turkey
ID NLM: 101709357

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 16 01 2024
accepted: 17 03 2024
medline: 4 4 2024
pubmed: 4 4 2024
entrez: 4 4 2024
Statut: epublish

Résumé

Despite advances in diagnosis and treatment, breast cancer is still one of the three most common cancers in the world and a significant cause of morbidity and mortality. Lipids play a role in many basic physiological pathways in cells, from regulating cell homeostasis to energy expenditure. As in many types of cancer, changes in lipid metabolism and their relationship have been reported in breast cancer. The

Identifiants

pubmed: 38571685
doi: 10.4274/ejbh.galenos.2024.2024-1-7
pii: 64791
pmc: PMC10985577
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

89-93

Informations de copyright

©Copyright 2024 by the Turkish Federation of Breast Diseases Societies / European Journal of Breast Health published by Galenos Publishing House.

Déclaration de conflit d'intérêts

Conflict of Interest: No conflict of interest was declared by the authors.

Auteurs

Almila Nazli Korucu (AN)

Yozgat Bozok University Faculty of Medicine, Yozgat, Turkey.

Nihal Inandiklioglu (N)

Department of Medical Biology, Yozgat Bozok University Faculty of Medicine, Yozgat, Turkey.

Classifications MeSH